Anti-hyperuricemic peptides derived from bonito hydrolysates based on in vivo hyperuricemic model and in vitro xanthine oxidase inhibitory activity
Y Li, X Kang, Q Li, C Shi, Y Lian, E Yuan, M Zhou… - Peptides, 2018 - Elsevier
Traditional drugs used to treat hyperuricemia have adverse effects. In this study, to identify
safer anti-hyperuricemic bioactive peptides isolated from food-derived protein hydrolysates …
safer anti-hyperuricemic bioactive peptides isolated from food-derived protein hydrolysates …
Anti-hyperuricemic peptides derived from bonito hydrolysates based on in vivo hyperuricemic model and in vitro xanthine oxidase inhibitory activity
Y Li, X Kang, Q Li, C Shi, Y Lian, E Yuan… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Traditional drugs used to treat hyperuricemia have adverse effects. In this study, to identify
safer anti-hyperuricemic bioactive peptides isolated from food-derived protein hydrolysates …
safer anti-hyperuricemic bioactive peptides isolated from food-derived protein hydrolysates …
Anti-hyperuricemic peptides derived from bonito hydrolysates based on in vivo hyperuricemic model and in vitro xanthine oxidase inhibitory activity.
Y Li, X Kang, Q Li, C Shi, Y Lian, E Yuan, M Zhou… - Peptides, 2018 - europepmc.org
Traditional drugs used to treat hyperuricemia have adverse effects. In this study, to identify
safer anti-hyperuricemic bioactive peptides isolated from food-derived protein hydrolysates …
safer anti-hyperuricemic bioactive peptides isolated from food-derived protein hydrolysates …